Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06452810 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area

A NA study of Skin Health, sponsored by Sahajan.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT06452810 is a NA study of Skin Health that has completed, run by Sahajan. The registered enrollment target is 35 participants, below the 52-participant average among 4 other Skin Health trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06452810, a NA study of Skin Health, has completed, sponsored by Sahajan.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This virtual single-group clinical trial aims to evaluate the effects of the Sahajan Golden Glow Balm on the health and appearance of the skin in the periorbital area over a period of 6 weeks. Participants will apply the product twice daily and complete questionnaires at various intervals. Photos for expert skin grading will be taken at Baseline and Week 6.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Experimental: Sahajan Golden Glow Balm

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2024-02-29
Est. Completion 2024-05-03
Phase NA

Sponsor

Sahajan

1 total trials

What the Registry Record Tells You About NCT06452810

The ClinicalTrials.gov registry entry for NCT06452810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52-participant average among 4 other Skin Health trials with a reported enrollment target (33% lower). The listed sponsor is Sahajan, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Health appearing as the primary indexed condition, and to 1 intervention - of which Experimental: Sahajan Golden Glow Balm is the first listed.

NCT06452810 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06452810 about?

NCT06452810 is a clinical study titled "A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area". This virtual single-group clinical trial aims to evaluate the effects of the Sahajan Golden Glow Balm on the health and appearance of the skin in the periorbital area over a period of 6 weeks. Participants will apply the product twice daily and complete questionnaires at various intervals. Photos fo...

What is the current status of trial NCT06452810?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2024-02-29. Estimated completion is 2024-05-03.

What conditions does trial NCT06452810 study?

This clinical trial studies the following conditions: Skin Health.

What interventions are being tested in trial NCT06452810?

The interventions under investigation include: Experimental: Sahajan Golden Glow Balm (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06452810?

This trial is sponsored by Sahajan, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06452810 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.